US Stock MarketDetailed Quotes

IOVA Iovance Biotherapeutics

Watchlist
  • 11.190
  • +0.750+7.18%
Close Nov 1 16:00 ET
  • 11.240
  • +0.050+0.45%
Post 19:58 ET
3.40BMarket Cap-6700P/E (TTM)

Iovance Biotherapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-4.77%-98.43M
-22.51%-122.28M
-23.59%-361.82M
-8.11%-83.97M
-32.10%-84.08M
-21.02%-93.95M
-35.25%-99.82M
-28.44%-292.76M
-44.24%-77.67M
-10.32%-63.65M
Net income from continuing operations
8.85%-97.1M
-5.22%-112.98M
-12.16%-444.04M
-10.50%-116.38M
-14.20%-113.76M
-7.23%-106.53M
-17.21%-107.37M
-15.67%-395.89M
-6.03%-105.32M
-15.67%-99.62M
Operating gains losses
--10K
---96K
--70K
---106K
--357K
----
----
----
----
----
Depreciation and amortization
38.55%10.86M
73.90%9.91M
56.74%33.13M
70.21%9.71M
89.83%9.88M
49.41%7.84M
14.44%5.7M
51.18%21.14M
27.84%5.71M
31.20%5.2M
Deferred tax
-205.66%-1.46M
---1.41M
---3.48M
---1.76M
---1.24M
---477K
--0
--0
--0
--0
Change In working capital
-237.50%-38.71M
-153.71%-32.55M
-125.48%-6.52M
295.87%11.89M
-45.73%5.89M
-77.66%-11.47M
-24.64%-12.83M
-111.78%-2.89M
-85.75%3M
182.44%10.85M
-Change in receivables
-94,960.61%-31.37M
---83K
---149K
----
----
---33K
--0
--0
----
----
-Change in inventory
7.23%-8.86M
---6.74M
---10.12M
---923K
--354K
---9.55M
--0
--0
--0
--0
-Change in prepaid assets
92.55%-211K
239.16%5.89M
-372.39%-10.06M
-280.89%-5.15M
192.92%2.15M
-368.88%-2.83M
-13.89%-4.23M
-176.76%-2.13M
26.04%2.85M
-165.12%-2.32M
-Change in payables and accrued expense
21.44%4.42M
-378.19%-28.83M
1,984.92%24.6M
744.95%20.83M
-55.02%6.17M
147.11%3.64M
17.05%-6.03M
-95.73%1.18M
-87.24%2.47M
391.75%13.71M
-Change in other current liabilities
0.11%-2.69M
-8.56%-2.79M
-455.82%-10.79M
-17.85%-2.72M
-424.81%-2.81M
-1,369.81%-2.69M
-472.32%-2.57M
66.98%-1.94M
-368.15%-2.31M
78.55%-536K
Cash from discontinued investing activities
Operating cash flow
-4.77%-98.43M
-22.51%-122.28M
-23.59%-361.82M
-8.11%-83.97M
-32.10%-84.08M
-21.02%-93.95M
-35.25%-99.82M
-28.44%-292.76M
-44.24%-77.67M
-10.32%-63.65M
Investing cash flow
Cash flow from continuing investing activities
125.65%40.22M
-172.69%-111.51M
-160.53%-155.24M
-15,901.52%-72.85M
-207.19%-79.01M
-263.72%-156.78M
77.30%153.4M
194,184.09%256.46M
-99.34%461K
478.25%73.72M
Net PPE purchase and sale
95.36%-442K
26.36%-4.17M
-9.13%-22.29M
-16.78%-3.53M
-157.89%-3.58M
-108.04%-9.52M
50.49%-5.66M
45.64%-20.43M
60.07%-3.02M
85.68%-1.39M
Net business purchase and sale
--0
---52.57M
---212.63M
--253K
---3.38M
---209.51M
--0
--0
--0
--0
Net investment purchase and sale
-34.68%40.66M
-134.43%-54.76M
-71.22%79.68M
-2,097.39%-69.57M
-195.95%-72.06M
-37.96%62.25M
62.38%159.06M
634.31%276.88M
-95.47%3.48M
234.78%75.1M
Cash from discontinued investing activities
Investing cash flow
125.65%40.22M
-172.69%-111.51M
-160.53%-155.24M
-15,901.52%-72.85M
-207.19%-79.01M
-263.72%-156.78M
77.30%153.4M
194,184.09%256.46M
-99.34%461K
478.25%73.72M
Financing cash flow
Cash flow from continuing financing activities
14,809.76%152.83M
-25.02%193.58M
143.47%462.96M
-99.50%962K
90,033.33%202.8M
149.59%1.03M
18,119.62%258.17M
-20.53%190.15M
4,492.17%190.58M
-98.92%225K
Net issuance payments of debt
----
----
--0
----
----
----
----
--0
----
----
Net common stock issuance
--151.87M
-23.91%197.91M
144.47%463.28M
-100.00%1K
--203.18M
--0
--260.1M
-6.72%189.5M
--189.5M
--0
Proceeds from stock option exercised by employees
47.21%1.95M
--364K
-24.99%2.47M
6.90%1.15M
--0
127.84%1.33M
--0
-90.61%3.3M
-74.14%1.07M
-98.92%225K
Net other financing activities
-232.23%-1M
-143.70%-4.7M
-5.51%-2.8M
---186K
---379K
---301K
---1.93M
---2.65M
--0
--0
Cash from discontinued financing activities
Financing cash flow
14,809.76%152.83M
-25.02%193.58M
143.47%462.96M
-99.50%962K
90,033.33%202.8M
149.59%1.03M
18,119.62%258.17M
-20.53%190.15M
4,492.17%190.58M
-98.92%225K
Net cash flow
Beginning cash position
-74.43%140.62M
-23.87%181.32M
182.47%238.16M
167.76%334.15M
158.89%296.44M
458.61%549.91M
182.47%238.16M
15.73%84.31M
92.96%124.8M
28.88%114.51M
Current changes in cash
137.89%94.62M
-112.90%-40.21M
-135.17%-54.1M
-237.48%-155.85M
285.80%39.7M
-1,654.74%-249.71M
2,106.16%311.75M
1,242.60%153.85M
477.24%113.37M
142.57%10.29M
Effect of exchange rate changes
96.68%-125K
---491K
---2.74M
--3.02M
---1.99M
---3.77M
--0
----
----
--0
End cash Position
-20.69%235.11M
-74.43%140.62M
-23.87%181.32M
-23.87%181.32M
167.76%334.15M
158.89%296.44M
458.61%549.91M
182.47%238.16M
182.47%238.16M
92.96%124.8M
Free cash flow
4.45%-98.87M
-19.88%-126.45M
-22.65%-384.11M
-8.43%-87.5M
-34.79%-87.66M
-25.86%-103.47M
-23.74%-105.48M
-17.95%-313.18M
-31.39%-80.69M
3.48%-65.04M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -4.77%-98.43M-22.51%-122.28M-23.59%-361.82M-8.11%-83.97M-32.10%-84.08M-21.02%-93.95M-35.25%-99.82M-28.44%-292.76M-44.24%-77.67M-10.32%-63.65M
Net income from continuing operations 8.85%-97.1M-5.22%-112.98M-12.16%-444.04M-10.50%-116.38M-14.20%-113.76M-7.23%-106.53M-17.21%-107.37M-15.67%-395.89M-6.03%-105.32M-15.67%-99.62M
Operating gains losses --10K---96K--70K---106K--357K--------------------
Depreciation and amortization 38.55%10.86M73.90%9.91M56.74%33.13M70.21%9.71M89.83%9.88M49.41%7.84M14.44%5.7M51.18%21.14M27.84%5.71M31.20%5.2M
Deferred tax -205.66%-1.46M---1.41M---3.48M---1.76M---1.24M---477K--0--0--0--0
Change In working capital -237.50%-38.71M-153.71%-32.55M-125.48%-6.52M295.87%11.89M-45.73%5.89M-77.66%-11.47M-24.64%-12.83M-111.78%-2.89M-85.75%3M182.44%10.85M
-Change in receivables -94,960.61%-31.37M---83K---149K-----------33K--0--0--------
-Change in inventory 7.23%-8.86M---6.74M---10.12M---923K--354K---9.55M--0--0--0--0
-Change in prepaid assets 92.55%-211K239.16%5.89M-372.39%-10.06M-280.89%-5.15M192.92%2.15M-368.88%-2.83M-13.89%-4.23M-176.76%-2.13M26.04%2.85M-165.12%-2.32M
-Change in payables and accrued expense 21.44%4.42M-378.19%-28.83M1,984.92%24.6M744.95%20.83M-55.02%6.17M147.11%3.64M17.05%-6.03M-95.73%1.18M-87.24%2.47M391.75%13.71M
-Change in other current liabilities 0.11%-2.69M-8.56%-2.79M-455.82%-10.79M-17.85%-2.72M-424.81%-2.81M-1,369.81%-2.69M-472.32%-2.57M66.98%-1.94M-368.15%-2.31M78.55%-536K
Cash from discontinued investing activities
Operating cash flow -4.77%-98.43M-22.51%-122.28M-23.59%-361.82M-8.11%-83.97M-32.10%-84.08M-21.02%-93.95M-35.25%-99.82M-28.44%-292.76M-44.24%-77.67M-10.32%-63.65M
Investing cash flow
Cash flow from continuing investing activities 125.65%40.22M-172.69%-111.51M-160.53%-155.24M-15,901.52%-72.85M-207.19%-79.01M-263.72%-156.78M77.30%153.4M194,184.09%256.46M-99.34%461K478.25%73.72M
Net PPE purchase and sale 95.36%-442K26.36%-4.17M-9.13%-22.29M-16.78%-3.53M-157.89%-3.58M-108.04%-9.52M50.49%-5.66M45.64%-20.43M60.07%-3.02M85.68%-1.39M
Net business purchase and sale --0---52.57M---212.63M--253K---3.38M---209.51M--0--0--0--0
Net investment purchase and sale -34.68%40.66M-134.43%-54.76M-71.22%79.68M-2,097.39%-69.57M-195.95%-72.06M-37.96%62.25M62.38%159.06M634.31%276.88M-95.47%3.48M234.78%75.1M
Cash from discontinued investing activities
Investing cash flow 125.65%40.22M-172.69%-111.51M-160.53%-155.24M-15,901.52%-72.85M-207.19%-79.01M-263.72%-156.78M77.30%153.4M194,184.09%256.46M-99.34%461K478.25%73.72M
Financing cash flow
Cash flow from continuing financing activities 14,809.76%152.83M-25.02%193.58M143.47%462.96M-99.50%962K90,033.33%202.8M149.59%1.03M18,119.62%258.17M-20.53%190.15M4,492.17%190.58M-98.92%225K
Net issuance payments of debt ----------0------------------0--------
Net common stock issuance --151.87M-23.91%197.91M144.47%463.28M-100.00%1K--203.18M--0--260.1M-6.72%189.5M--189.5M--0
Proceeds from stock option exercised by employees 47.21%1.95M--364K-24.99%2.47M6.90%1.15M--0127.84%1.33M--0-90.61%3.3M-74.14%1.07M-98.92%225K
Net other financing activities -232.23%-1M-143.70%-4.7M-5.51%-2.8M---186K---379K---301K---1.93M---2.65M--0--0
Cash from discontinued financing activities
Financing cash flow 14,809.76%152.83M-25.02%193.58M143.47%462.96M-99.50%962K90,033.33%202.8M149.59%1.03M18,119.62%258.17M-20.53%190.15M4,492.17%190.58M-98.92%225K
Net cash flow
Beginning cash position -74.43%140.62M-23.87%181.32M182.47%238.16M167.76%334.15M158.89%296.44M458.61%549.91M182.47%238.16M15.73%84.31M92.96%124.8M28.88%114.51M
Current changes in cash 137.89%94.62M-112.90%-40.21M-135.17%-54.1M-237.48%-155.85M285.80%39.7M-1,654.74%-249.71M2,106.16%311.75M1,242.60%153.85M477.24%113.37M142.57%10.29M
Effect of exchange rate changes 96.68%-125K---491K---2.74M--3.02M---1.99M---3.77M--0----------0
End cash Position -20.69%235.11M-74.43%140.62M-23.87%181.32M-23.87%181.32M167.76%334.15M158.89%296.44M458.61%549.91M182.47%238.16M182.47%238.16M92.96%124.8M
Free cash flow 4.45%-98.87M-19.88%-126.45M-22.65%-384.11M-8.43%-87.5M-34.79%-87.66M-25.86%-103.47M-23.74%-105.48M-17.95%-313.18M-31.39%-80.69M3.48%-65.04M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data